Brenntag lifts 2026 profit guidance, shares struggle despite strong quarter
23.06.2026 - 20:23:58 | ad-hoc-news.de
By Anna Wagner, Analysts & Consensus desk. Reviewed prior to publication on 2026-06-23, 20:22.
Brenntag (DE000A1DAHH0) has raised its full-year 2026 operating EBITDA guidance after reporting a markedly strong preliminary second quarter, with the DAX-listed chemicals distributor still seeing its shares trade lower on Xetra as investors digest the upgrade. The company now targets operating EBITDA between 1.25 billion and 1.40 billion euros for 2026, up from 1.15 billion to 1.35 billion euros, citing robust demand and improved margins.
What the guidance change shows
The new guidance range reflects Brenntag’s preliminary operating EBITDA of around 450 million euros for the second quarter of 2026, a clear step above the prior year’s 334 million euros reported for the same period. According to analyst estimates compiled by Vara Research and cited by Investing.com, consensus for the quarter stood at roughly 366.9 million euros, making the preliminary figure a noticeable beat.
Jefferies calculated that the 450 million euros result represents a roughly 35 percent year-over-year increase and about a 27 percent beat versus its own estimate of 353 million euros, underlining the strength of Brenntag’s current trading momentum. Management attributes the performance primarily to robust demand in key end-markets and improved margins, particularly in the context of supply and price dislocations linked to the crisis in the Middle East.
Analysts react to the upgrade
Despite the numbers, the analyst community remains cautious on the stock, with several houses reiterating neutral stances and one major bank sticking to a sell view. Jefferies keeps a Hold rating on Brenntag shares alongside a price target of 56 euros, noting that the updated 2026 guidance range is broadly in line with the current consensus of around 1.33 billion euros at the midpoint.
Deutsche Bank analyst Tristan Lamotte likewise maintains a Neutral recommendation and a 57 euros target price, underscoring that while the preliminary results are surprisingly strong, they do not fundamentally change the longer-term risk-reward profile. UBS also reiterates its Neutral rating, and JP Morgan continues to rate the shares Sell according to MarketScreener’s aggregation of recent research notes. This mix of views helps explain why the stock is seeing muted price action despite the guidance lift.
Further news and data on the Brenntag shares
All recent articles, quotes and key figures on Brenntag are available via the dedicated topic page and the company’s investor relations section.
How the business delivers earnings
Brenntag operates as a global chemicals distributor, positioned between large producers and a fragmented base of industrial and specialty users. The group sources bulk and specialty chemicals, repackages them where needed, and provides formulation, logistics and technical services for sectors ranging from food and nutrition to coatings, water treatment and oil and gas.
Where the Brenntag shares trade today
The Brenntag shares (DE000A1DAHH0) recently traded on Xetra around 53.1 euros, with real-time data at 11:19 citing a quote of 53.12 euros, down roughly 4.5 percent from the previous day’s close of 55.64 euros.
Key data on the Brenntag shares
- Company: Brenntag SE
- ISIN: DE000A1DAHH0
- WKN: A1DAHH
- Ticker: BNR
- Trading venue: Xetra
- Price (as of 2026-06-23, 11:19): 53.12 EUR
- Market cap: approximately 8.5 billion EUR (as of 2026-06-23)
- Sector / industry: Chemicals distribution / industrial services
- Index membership: DAX
- Next earnings date: not officially scheduled
Disclaimer: This article is for informational purposes only and does not constitute investment advice or a recommendation to buy or sell securities. All data are based on sources believed to be reliable but may be subject to change. Investors should conduct their own research or consult a professional advisor before making investment decisions.
